| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 4.83e-06 | 37 | 61 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 1.40e-05 | 363 | 61 | 8 | GO:0106310 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP8B3 ARL4A HSP90B2P GBP4 GBP7 RTEL1 CHD5 RSF1 CHD1 CHD2 KIF7 | 1.99e-05 | 775 | 61 | 11 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATP8B3 ARL4A HSP90B2P GBP4 GBP7 RTEL1 CHD5 RSF1 CHD1 CHD2 KIF7 | 4.12e-05 | 839 | 61 | 11 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATP8B3 ARL4A HSP90B2P GBP4 GBP7 RTEL1 CHD5 RSF1 CHD1 CHD2 KIF7 | 4.17e-05 | 840 | 61 | 11 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATP8B3 ARL4A HSP90B2P GBP4 GBP7 RTEL1 CHD5 RSF1 CHD1 CHD2 KIF7 | 4.17e-05 | 840 | 61 | 11 | GO:0016818 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 4.30e-05 | 127 | 61 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 5.61e-05 | 441 | 61 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 6.07e-05 | 446 | 61 | 8 | GO:0004674 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 2.83e-04 | 709 | 61 | 9 | GO:0016773 | |
| GeneOntologyMolecularFunction | protein kinase activity | 4.59e-04 | 600 | 61 | 8 | GO:0004672 | |
| GeneOntologyMolecularFunction | kinase activity | 4.89e-04 | 764 | 61 | 9 | GO:0016301 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 5.35e-04 | 614 | 61 | 8 | GO:0140657 | |
| GeneOntologyMolecularFunction | protein antigen binding | 1.07e-03 | 16 | 61 | 2 | GO:1990405 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.22e-03 | 262 | 61 | 5 | GO:0140097 | |
| GeneOntologyMolecularFunction | histone binding | 1.29e-03 | 265 | 61 | 5 | GO:0042393 | |
| GeneOntologyMolecularFunction | helicase activity | 1.39e-03 | 158 | 61 | 4 | GO:0004386 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 1.68e-03 | 20 | 61 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 2.06e-03 | 938 | 61 | 9 | GO:0016772 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 3.78e-03 | 30 | 61 | 2 | GO:0004693 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 3.78e-03 | 30 | 61 | 2 | GO:0097472 | |
| GeneOntologyCellularComponent | host cell part | 1.29e-04 | 6 | 62 | 2 | GO:0033643 | |
| GeneOntologyCellularComponent | host intracellular part | 1.29e-04 | 6 | 62 | 2 | GO:0033646 | |
| GeneOntologyCellularComponent | host cell cytoplasm part | 1.29e-04 | 6 | 62 | 2 | GO:0033655 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole | 1.29e-04 | 6 | 62 | 2 | GO:0020003 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole membrane | 1.29e-04 | 6 | 62 | 2 | GO:0020005 | |
| GeneOntologyCellularComponent | host intracellular region | 1.29e-04 | 6 | 62 | 2 | GO:0043656 | |
| GeneOntologyCellularComponent | host cell cytoplasm | 1.29e-04 | 6 | 62 | 2 | GO:0030430 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.90e-04 | 96 | 62 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | ATPase complex | 5.85e-04 | 129 | 62 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | host cellular component | 8.86e-04 | 15 | 62 | 2 | GO:0018995 | |
| GeneOntologyCellularComponent | CHD-type complex | 1.14e-03 | 17 | 62 | 2 | GO:0090545 | |
| GeneOntologyCellularComponent | NuRD complex | 1.14e-03 | 17 | 62 | 2 | GO:0016581 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 2.06e-03 | 85 | 62 | 3 | GO:0000118 | |
| GeneOntologyCellularComponent | trans-Golgi network | 2.13e-03 | 306 | 62 | 5 | GO:0005802 | |
| HumanPheno | Broad nasal tip | 3.10e-05 | 159 | 21 | 6 | HP:0000455 | |
| HumanPheno | Abnormality of upper lip vermillion | 4.33e-05 | 464 | 21 | 9 | HP:0011339 | |
| HumanPheno | Abnormal lip morphology | SETD1B MTOR CHD5 BUB1 HGSNAT SMARCC2 CHD2 DENND5A PLG CPLANE1 CDC42BPB GATAD2B RYR1 KIF7 | 5.19e-05 | 1249 | 21 | 14 | HP:0000159 |
| HumanPheno | Enlarged posterior fossa | 9.22e-05 | 193 | 21 | 6 | HP:0005445 | |
| HumanPheno | Abnormal eyebrow morphology | SETD1B RTEL1 CHD5 HGSNAT SMARCC2 CHD1 DENND5A CPLANE1 CDC42BPB KIF7 | 1.37e-04 | 674 | 21 | 10 | HP:0000534 |
| HumanPheno | Macrostomia | 1.91e-04 | 220 | 21 | 6 | HP:0000181 | |
| HumanPheno | Wide mouth | 1.91e-04 | 220 | 21 | 6 | HP:0000154 | |
| HumanPheno | Thin vermilion border | 1.93e-04 | 433 | 21 | 8 | HP:0000233 | |
| HumanPheno | Abnormal posterior cranial fossa morphology | 1.95e-04 | 221 | 21 | 6 | HP:0000932 | |
| HumanPheno | Dandy-Walker malformation | 2.15e-04 | 141 | 21 | 5 | HP:0001305 | |
| HumanPheno | Giant somatosensory evoked potentials | 2.62e-04 | 147 | 21 | 5 | HP:0001312 | |
| HumanPheno | Thin upper lip vermilion | 2.80e-04 | 339 | 21 | 7 | HP:0000219 | |
| HumanPheno | Thin lips | 2.80e-04 | 339 | 21 | 7 | HP:0000213 | |
| HumanPheno | Abnormal skull base morphology | 3.21e-04 | 242 | 21 | 6 | HP:0002693 | |
| HumanPheno | Abnormal nervous system electrophysiology | SETD1B MTOR BUB1 CLN6 SMARCC2 CHD2 DENND5A PLG CPLANE1 RYR1 KIF7 | 3.93e-04 | 924 | 21 | 11 | HP:0001311 |
| HumanPheno | Abnormality of somatosensory evoked potentials | 4.00e-04 | 161 | 21 | 5 | HP:0007377 | |
| HumanPheno | Abnormal fourth ventricle morphology | 4.48e-04 | 165 | 21 | 5 | HP:0010950 | |
| HumanPheno | Dilated fourth ventricle | 4.48e-04 | 165 | 21 | 5 | HP:0002198 | |
| HumanPheno | Cerebellar cyst | 4.61e-04 | 166 | 21 | 5 | HP:0002350 | |
| HumanPheno | Aplasia/Hypoplasia of the cerebellar vermis | 4.72e-04 | 369 | 21 | 7 | HP:0006817 | |
| HumanPheno | Cerebellar vermis hypoplasia | 4.72e-04 | 369 | 21 | 7 | HP:0001320 | |
| HumanPheno | Abnormal cerebellar vermis morphology | 5.12e-04 | 374 | 21 | 7 | HP:0002334 | |
| HumanPheno | Abnormality of calvarial morphology | SETD1B MTOR CHD5 BUB1 HGSNAT CHD1 DENND5A CPLANE1 CDC42BPB GATAD2B RYR1 KIF7 | 5.42e-04 | 1134 | 21 | 12 | HP:0002648 |
| HumanPheno | Abnormal nasal tip morphology | 6.21e-04 | 386 | 21 | 7 | HP:0000436 | |
| HumanPheno | Abnormal upper lip morphology | MTOR CHD5 BUB1 SMARCC2 CHD2 DENND5A CPLANE1 CDC42BPB GATAD2B RYR1 KIF7 | 6.69e-04 | 980 | 21 | 11 | HP:0000177 |
| HumanPheno | Midline notch of upper alveolar ridge | 7.14e-04 | 10 | 21 | 2 | HP:0009084 | |
| MousePheno | abnormal mammary gland connective tissue morphology | 1.11e-05 | 2 | 47 | 2 | MP:0009507 | |
| MousePheno | esophageal ulcer | 1.11e-05 | 2 | 47 | 2 | MP:0004547 | |
| MousePheno | duodenal ulcer | 1.11e-05 | 2 | 47 | 2 | MP:0003273 | |
| MousePheno | perianal ulcer | 1.11e-05 | 2 | 47 | 2 | MP:0005035 | |
| MousePheno | ectropion | 1.11e-05 | 2 | 47 | 2 | MP:0006164 | |
| MousePheno | absent cornea epithelium | 3.31e-05 | 3 | 47 | 2 | MP:0020856 | |
| MousePheno | decreased cell migration | 6.53e-05 | 65 | 47 | 4 | MP:0011805 | |
| MousePheno | increased circulating fibrinogen level | 6.61e-05 | 4 | 47 | 2 | MP:0012331 | |
| MousePheno | proctitis | 6.61e-05 | 4 | 47 | 2 | MP:0003305 | |
| MousePheno | abnormal choroid vasculature morphology | 9.85e-05 | 27 | 47 | 3 | MP:0006237 | |
| MousePheno | hepatic necrosis | 1.40e-04 | 79 | 47 | 4 | MP:0001654 | |
| MousePheno | gastric ulcer | 1.65e-04 | 6 | 47 | 2 | MP:0003282 | |
| MousePheno | increased acute phase protein level | 2.30e-04 | 7 | 47 | 2 | MP:0014499 | |
| MousePheno | abnormal conjunctival epithelium morphology | 2.30e-04 | 7 | 47 | 2 | MP:0004481 | |
| MousePheno | venoocclusion | 2.30e-04 | 7 | 47 | 2 | MP:0006137 | |
| MousePheno | peptic ulcer | 2.30e-04 | 7 | 47 | 2 | MP:0003301 | |
| MousePheno | oligozoospermia | 2.72e-04 | 384 | 47 | 7 | MP:0002687 | |
| MousePheno | decreased keratinocyte migration | 3.06e-04 | 8 | 47 | 2 | MP:0012194 | |
| MousePheno | abnormal circulating fibrinogen level | 3.06e-04 | 8 | 47 | 2 | MP:0010213 | |
| MousePheno | impaired wound healing | 3.73e-04 | 42 | 47 | 3 | MP:0001792 | |
| MousePheno | decreased susceptibility to induced choroidal neovascularization | 4.89e-04 | 10 | 47 | 2 | MP:0003434 | |
| MousePheno | abnormal kidney thrombosis | 4.89e-04 | 10 | 47 | 2 | MP:0011507 | |
| MousePheno | abnormal cell motility | 5.95e-04 | 885 | 47 | 10 | MP:0020846 | |
| MousePheno | abnormal keratinocyte migration | 5.97e-04 | 11 | 47 | 2 | MP:0012192 | |
| MousePheno | pulmonary artery hypoplasia | 5.97e-04 | 11 | 47 | 2 | MP:0010460 | |
| MousePheno | abnormal optic choroid morphology | 7.01e-04 | 52 | 47 | 3 | MP:0005098 | |
| MousePheno | decreased apoptosis | 8.10e-04 | 219 | 47 | 5 | MP:0006043 | |
| MousePheno | abnormal anus morphology | 8.43e-04 | 13 | 47 | 2 | MP:0005034 | |
| MousePheno | abnormal conjunctiva morphology | 8.43e-04 | 13 | 47 | 2 | MP:0001310 | |
| MousePheno | decreased cell death | 8.78e-04 | 223 | 47 | 5 | MP:0012555 | |
| MousePheno | small ectoplacental cone | 9.81e-04 | 14 | 47 | 2 | MP:0002584 | |
| Domain | Chromo/shadow_dom | 2.58e-06 | 33 | 55 | 4 | IPR000953 | |
| Domain | CHROMO | 2.58e-06 | 33 | 55 | 4 | SM00298 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 3.29e-06 | 35 | 55 | 4 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 4.61e-06 | 38 | 55 | 4 | PS00690 | |
| Domain | DUF4208 | 2.55e-05 | 3 | 55 | 2 | PF13907 | |
| Domain | DUF4208 | 2.55e-05 | 3 | 55 | 2 | SM01176 | |
| Domain | DUF4208 | 2.55e-05 | 3 | 55 | 2 | IPR025260 | |
| Domain | Chromo_domain | 4.68e-05 | 24 | 55 | 3 | IPR023780 | |
| Domain | Chromo | 5.99e-05 | 26 | 55 | 3 | PF00385 | |
| Domain | CHROMO_1 | 7.51e-05 | 28 | 55 | 3 | PS00598 | |
| Domain | CHROMO_2 | 7.51e-05 | 28 | 55 | 3 | PS50013 | |
| Domain | Ser/Thr_kinase_AS | 8.11e-05 | 357 | 55 | 7 | IPR008271 | |
| Domain | S_TKc | 8.39e-05 | 359 | 55 | 7 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 8.84e-05 | 362 | 55 | 7 | PS00108 | |
| Domain | SNF2_N | 1.13e-04 | 32 | 55 | 3 | IPR000330 | |
| Domain | Chromodomain-like | 1.13e-04 | 32 | 55 | 3 | IPR016197 | |
| Domain | SNF2_N | 1.13e-04 | 32 | 55 | 3 | PF00176 | |
| Domain | Pkinase | 1.22e-04 | 381 | 55 | 7 | PF00069 | |
| Domain | Kinase-like_dom | 1.75e-04 | 542 | 55 | 8 | IPR011009 | |
| Domain | GBP_C | 3.77e-04 | 10 | 55 | 2 | PF02841 | |
| Domain | PROTEIN_KINASE_ATP | 3.79e-04 | 459 | 55 | 7 | PS00107 | |
| Domain | G_GB1_RHD3_dom | 4.60e-04 | 11 | 55 | 2 | IPR030386 | |
| Domain | Guanylate-bd_C | 4.60e-04 | 11 | 55 | 2 | IPR003191 | |
| Domain | GBP | 4.60e-04 | 11 | 55 | 2 | PF02263 | |
| Domain | Guanylate-bd_N | 4.60e-04 | 11 | 55 | 2 | IPR015894 | |
| Domain | G_GB1_RHD3 | 4.60e-04 | 11 | 55 | 2 | PS51715 | |
| Domain | Prot_kinase_dom | 5.53e-04 | 489 | 55 | 7 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 5.80e-04 | 493 | 55 | 7 | PS50011 | |
| Domain | HEAT | 6.65e-04 | 58 | 55 | 3 | IPR000357 | |
| Domain | Protein_kinase_ATP_BS | 8.41e-04 | 379 | 55 | 6 | IPR017441 | |
| Domain | Kringle | 1.13e-03 | 17 | 55 | 2 | IPR000001 | |
| Domain | Kringle_CS | 1.13e-03 | 17 | 55 | 2 | IPR018056 | |
| Domain | KRINGLE_2 | 1.13e-03 | 17 | 55 | 2 | PS50070 | |
| Domain | Kringle | 1.13e-03 | 17 | 55 | 2 | PF00051 | |
| Domain | KRINGLE_1 | 1.13e-03 | 17 | 55 | 2 | PS00021 | |
| Domain | KR | 1.13e-03 | 17 | 55 | 2 | SM00130 | |
| Domain | HEAT_REPEAT | 1.15e-03 | 70 | 55 | 3 | PS50077 | |
| Domain | Chromodomain_CS | 1.26e-03 | 18 | 55 | 2 | IPR023779 | |
| Domain | DAG/PE-bd | 1.72e-03 | 21 | 55 | 2 | IPR020454 | |
| Domain | P-loop_NTPase | 3.20e-03 | 848 | 55 | 8 | IPR027417 | |
| Domain | - | 3.51e-03 | 30 | 55 | 2 | 1.20.1270.60 | |
| Domain | AH/BAR-dom | 3.51e-03 | 30 | 55 | 2 | IPR027267 | |
| Domain | Helicase_C | 3.86e-03 | 107 | 55 | 3 | PF00271 | |
| Domain | HELICc | 3.86e-03 | 107 | 55 | 3 | SM00490 | |
| Domain | Helicase_C | 3.97e-03 | 108 | 55 | 3 | IPR001650 | |
| Domain | Kringle-like | 3.99e-03 | 32 | 55 | 2 | IPR013806 | |
| Domain | HELICASE_CTER | 4.07e-03 | 109 | 55 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 4.07e-03 | 109 | 55 | 3 | PS51192 | |
| Domain | DEXDc | 4.07e-03 | 109 | 55 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 4.17e-03 | 110 | 55 | 3 | IPR014001 | |
| Domain | Pkinase_C | 5.31e-03 | 37 | 55 | 2 | IPR017892 | |
| Pathway | BIOCARTA_FIBRINOLYSIS_PATHWAY | 6.55e-06 | 12 | 45 | 3 | MM1398 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 5.15e-05 | 23 | 45 | 3 | MM15936 | |
| Pubmed | Multiple members of the plasminogen-apolipoprotein(a) gene family associated with thrombosis. | 2.37e-08 | 4 | 64 | 3 | 1554698 | |
| Pubmed | Two types of abnormal genes for plasminogen in families with a predisposition for thrombosis. | 2.37e-08 | 4 | 64 | 3 | 1986355 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 21900290 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 31690812 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 30254165 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 38328826 | ||
| Pubmed | Reduced transplant arteriosclerosis in plasminogen-deficient mice. | 3.33e-06 | 2 | 64 | 2 | 9819364 | |
| Pubmed | Association between lipoprotein(a) and ischemic stroke: Fibrinogen as a mediator. | 3.33e-06 | 2 | 64 | 2 | 37517272 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 21142871 | ||
| Pubmed | Persistent corneal haze after excimer laser photokeratectomy in plasminogen-deficient mice. | 3.33e-06 | 2 | 64 | 2 | 10634603 | |
| Pubmed | Thrombomodulin functions as a plasminogen receptor to modulate angiogenesis. | 3.33e-06 | 2 | 64 | 2 | 23943648 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12083480 | ||
| Pubmed | Polymorphonuclear leukocyte phagocytic function increases in plasminogen knockout mice. | 3.33e-06 | 2 | 64 | 2 | 18420257 | |
| Pubmed | Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. | 3.33e-06 | 2 | 64 | 2 | 7705657 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 23041318 | ||
| Pubmed | ARL4A acts with GCC185 to modulate Golgi complex organization. | 3.33e-06 | 2 | 64 | 2 | 22159419 | |
| Pubmed | Plasminogen alleles influence susceptibility to invasive aspergillosis. | 3.33e-06 | 2 | 64 | 2 | 18566672 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 19752236 | ||
| Pubmed | CHD1 and CHD2 are positive regulators of HIV-1 gene expression. | 3.33e-06 | 2 | 64 | 2 | 25297984 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 6216475 | ||
| Pubmed | The generation and characterization of mice expressing a plasmin-inactivating active site mutation. | 3.33e-06 | 2 | 64 | 2 | 20653841 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12428098 | ||
| Pubmed | Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus. | 3.33e-06 | 2 | 64 | 2 | 20440070 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 24732409 | ||
| Pubmed | A central role for plasminogen in the inflammatory response to biomaterials. | 3.33e-06 | 2 | 64 | 2 | 15456492 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 24876560 | ||
| Pubmed | Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in mice. | 3.33e-06 | 2 | 64 | 2 | 24574269 | |
| Pubmed | Spontaneous development of otitis media in plasminogen-deficient mice. | 3.33e-06 | 2 | 64 | 2 | 16956791 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 25409527 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 1543918 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 8704243 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 17267741 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 23702659 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 29990619 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 17293777 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 23456978 | ||
| Pubmed | Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. | 3.33e-06 | 2 | 64 | 2 | 10854210 | |
| Pubmed | Gender affects skin wound healing in plasminogen deficient mice. | 3.33e-06 | 2 | 64 | 2 | 23527289 | |
| Pubmed | Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation. | 3.33e-06 | 2 | 64 | 2 | 22079981 | |
| Pubmed | Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. | 3.33e-06 | 2 | 64 | 2 | 9490683 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 16481742 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18983515 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 34378815 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 11848464 | ||
| Pubmed | Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. | 3.33e-06 | 2 | 64 | 2 | 7586361 | |
| Pubmed | Plasminogen/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function. | 3.33e-06 | 2 | 64 | 2 | 21239499 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 10642175 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12225871 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 9770530 | ||
| Pubmed | Plasminogen activation is required for the development of radiation-induced dermatitis. | 3.33e-06 | 2 | 64 | 2 | 30323258 | |
| Pubmed | Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression. | 3.33e-06 | 2 | 64 | 2 | 37971174 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 9884337 | ||
| Pubmed | Colonic Lesions, Cytokine Profiles, and Gut Microbiota in Plasminogen-Deficient Mice. | 3.33e-06 | 2 | 64 | 2 | 26473342 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 10816371 | ||
| Pubmed | Plasminogen is a critical regulator of cutaneous wound healing. | 3.33e-06 | 2 | 64 | 2 | 26791370 | |
| Pubmed | Selection of mutant µplasmin for amyloid-β cleavage in vivo. | 3.33e-06 | 2 | 64 | 2 | 32694536 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 7525077 | ||
| Pubmed | Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models. | 3.33e-06 | 2 | 64 | 2 | 16052596 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 17122079 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 16103174 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 21300353 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15737740 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 11306011 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12149246 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 22056679 | ||
| Pubmed | Protective effects of plasmin(ogen) in a mouse model of Staphylococcus aureus-induced arthritis. | 3.33e-06 | 2 | 64 | 2 | 18311818 | |
| Pubmed | Localization of plasminogen in mouse hippocampus, cerebral cortex, and hypothalamus. | 3.33e-06 | 2 | 64 | 2 | 21190118 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18039665 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 9671388 | ||
| Pubmed | A physiological function for apolipoprotein(a): a natural regulator of the inflammatory response. | 3.33e-06 | 2 | 64 | 2 | 18997104 | |
| Pubmed | Growth and behavioral development in plasminogen gene-targeted mice. | 3.33e-06 | 2 | 64 | 2 | 10885855 | |
| Pubmed | Cellular density regulation of plasminogen gene expression in mouse hepatocytes. | 3.33e-06 | 2 | 64 | 2 | 12559391 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 27319402 | ||
| Pubmed | Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. | 3.33e-06 | 2 | 64 | 2 | 15333838 | |
| Pubmed | Apo(a) promotes thrombosis in a vascular injury model by a mechanism independent of plasminogen. | 3.33e-06 | 2 | 64 | 2 | 16150044 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 11916082 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 9659399 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 37621179 | ||
| Pubmed | Unaltered prion protein cleavage in plasminogen-deficient mice. | 3.33e-06 | 2 | 64 | 2 | 16543819 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 34423816 | ||
| Pubmed | Delayed invasion of the kidney and brain by Borrelia crocidurae in plasminogen-deficient mice. | 3.33e-06 | 2 | 64 | 2 | 11500461 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 10980194 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12167431 | ||
| Pubmed | Impaired wound healing in mice with a disrupted plasminogen gene. | 3.33e-06 | 2 | 64 | 2 | 8612226 | |
| Pubmed | Role of plasminogen activation in neuronal organization and survival. | 3.33e-06 | 2 | 64 | 2 | 19683575 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 10537128 | ||
| Pubmed | Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis. | 3.33e-06 | 2 | 64 | 2 | 23555246 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18685433 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 31462325 | ||
| Pubmed | Homozygous mutations in the plasminogen gene of two unrelated girls with ligneous conjunctivitis. | 3.33e-06 | 2 | 64 | 2 | 9242524 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SYNE3 SETD1B MTOR CASKIN1 CHD5 RAPGEF1 DENND5A PIP5K1C CDC42BPB RYR1 PICK1 | 5.04e-06 | 1105 | 64 | 11 | 35748872 |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 16818777 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 19273908 | ||
| Pubmed | Lactational competence and involution of the mouse mammary gland require plasminogen. | 9.99e-06 | 3 | 64 | 2 | 11003846 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 28320709 | ||
| Pubmed | Plasminogen directs the pleiotropic effects of uPA in liver injury and repair. | 9.99e-06 | 3 | 64 | 2 | 12431907 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 16413499 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 33827130 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 24612416 | ||
| Pubmed | In vivo regulation of plasminogen function by plasma carboxypeptidase B. | 9.99e-06 | 3 | 64 | 2 | 12417566 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q26 | 2.27e-04 | 16 | 64 | 2 | chr6q26 | |
| Cytoband | 6q26 | 2.89e-04 | 18 | 64 | 2 | 6q26 | |
| Cytoband | 1p22.2 | 7.06e-04 | 28 | 64 | 2 | 1p22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p22 | 9.48e-04 | 137 | 64 | 3 | chr1p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q26 | 3.03e-03 | 206 | 64 | 3 | chr15q26 | |
| GeneFamily | DNA helicases | 4.86e-04 | 17 | 35 | 2 | 1167 | |
| GeneFamily | Cyclin dependent kinases | 1.15e-03 | 26 | 35 | 2 | 496 | |
| ToppCell | TCGA-Liver|World / Sample_Type by Project: Shred V9 | 1.91e-07 | 174 | 64 | 6 | 452932f08cf53e5949672a025d78cecb874aa4b0 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.98e-07 | 175 | 64 | 6 | 7f74961436f88c0e380819095e6104489914d765 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.98e-07 | 175 | 64 | 6 | bee8f31f036dfcf9fc6ed29156554771a9ee3c60 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.93e-06 | 199 | 64 | 5 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| Drug | Fibrin | 7.08e-09 | 9 | 64 | 4 | CID000439199 | |
| Drug | NSC-270916 | 3.46e-06 | 82 | 64 | 5 | CID000002949 | |
| Drug | Spectrozyme Pl | 7.54e-06 | 14 | 64 | 3 | CID000128903 | |
| Drug | 1-Behenyl-2-lauryl-sn-glycero-3-phosphocholine | 7.78e-06 | 2 | 64 | 2 | CID000129220 | |
| Drug | Aminocaproic Acid | 2.33e-05 | 3 | 64 | 2 | DB00513 | |
| Drug | tulipanin | 2.33e-05 | 3 | 64 | 2 | CID000192918 | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 2.92e-07 | 7 | 61 | 3 | EFO_0004614, EFO_0006925 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 7.32e-07 | 34 | 61 | 4 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | Epileptic encephalopathy | 3.28e-05 | 30 | 61 | 3 | C0543888 | |
| Disease | chronic kidney disease, APOL1 risk genotype carrier status | 4.19e-05 | 5 | 61 | 2 | EFO_0003884, EFO_0009324 | |
| Disease | plasma plasminogen measurement | 4.19e-05 | 5 | 61 | 2 | EFO_0006309 | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 4.81e-05 | 34 | 61 | 3 | EFO_0008317, EFO_0008596, EFO_0020947 | |
| Disease | angiostatin measurement | 6.27e-05 | 6 | 61 | 2 | EFO_0008024 | |
| Disease | OROFACIODIGITAL SYNDROME VI | 8.77e-05 | 7 | 61 | 2 | C2745997 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 9.11e-05 | 42 | 61 | 3 | EFO_0022255 | |
| Disease | prostate cancer (is_implicated_in) | 1.03e-04 | 117 | 61 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.20e-04 | 46 | 61 | 3 | EFO_0008317, EFO_0008596, EFO_0020943 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 1.54e-04 | 50 | 61 | 3 | EFO_0022303 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 1.63e-04 | 51 | 61 | 3 | EFO_0022302 | |
| Disease | cholesterol to total lipids in small HDL percentage | 1.63e-04 | 51 | 61 | 3 | EFO_0022240 | |
| Disease | monokine induced by gamma interferon measurement | 1.73e-04 | 52 | 61 | 3 | EFO_0008236 | |
| Disease | triglycerides in HDL measurement | 1.83e-04 | 53 | 61 | 3 | EFO_0022317 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 1.83e-04 | 53 | 61 | 3 | EFO_0022286 | |
| Disease | triglycerides in medium HDL measurement | 1.93e-04 | 54 | 61 | 3 | EFO_0022321 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 2.16e-04 | 56 | 61 | 3 | EFO_0022333 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 2.16e-04 | 56 | 61 | 3 | EFO_0022279 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 2.16e-04 | 56 | 61 | 3 | EFO_0022251 | |
| Disease | low density lipoprotein particle size measurement | 2.39e-04 | 58 | 61 | 3 | EFO_0008593 | |
| Disease | triglycerides to total lipids in small LDL percentage | 2.52e-04 | 59 | 61 | 3 | EFO_0022337 | |
| Disease | triglycerides to total lipids in large HDL percentage | 2.65e-04 | 60 | 61 | 3 | EFO_0022330 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 2.65e-04 | 60 | 61 | 3 | EFO_0022237 | |
| Disease | triglycerides in small VLDL measurement | 2.78e-04 | 61 | 61 | 3 | EFO_0022145 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.88e-04 | 153 | 61 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.88e-04 | 153 | 61 | 4 | EFO_0004611, EFO_0020944 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 2.91e-04 | 62 | 61 | 3 | EFO_0022339 | |
| Disease | triglycerides in small HDL measurement | 2.91e-04 | 62 | 61 | 3 | EFO_0022158 | |
| Disease | phospholipids in large VLDL measurement | 2.91e-04 | 62 | 61 | 3 | EFO_0022169 | |
| Disease | free cholesterol in very large HDL measurement | 2.91e-04 | 62 | 61 | 3 | EFO_0022273 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 3.06e-04 | 63 | 61 | 3 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 3.06e-04 | 63 | 61 | 3 | EFO_0022239 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 3.06e-04 | 63 | 61 | 3 | EFO_0022283 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 3.20e-04 | 64 | 61 | 3 | EFO_0022253 | |
| Disease | triglycerides in small LDL measurement | 3.35e-04 | 65 | 61 | 3 | EFO_0022323 | |
| Disease | total lipids in very large HDL measurement | 3.51e-04 | 66 | 61 | 3 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 3.51e-04 | 66 | 61 | 3 | EFO_0022298 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 3.66e-04 | 67 | 61 | 3 | EFO_0022245 | |
| Disease | triglycerides to phosphoglycerides ratio | 3.83e-04 | 68 | 61 | 3 | EFO_0022327 | |
| Disease | free cholesterol in large VLDL measurement | 3.83e-04 | 68 | 61 | 3 | EFO_0022265 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 4.00e-04 | 69 | 61 | 3 | EFO_0022341 | |
| Disease | cholesterol in very large HDL measurement | 4.00e-04 | 69 | 61 | 3 | EFO_0022229 | |
| Disease | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 4.34e-04 | 15 | 61 | 2 | EFO_0022328 | |
| Disease | triglycerides to total lipids in small HDL percentage | 4.53e-04 | 72 | 61 | 3 | EFO_0022336 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 4.91e-04 | 74 | 61 | 3 | EFO_0022280 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 5.11e-04 | 75 | 61 | 3 | EFO_0022287 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 5.60e-04 | 17 | 61 | 2 | EFO_0022232 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 5.60e-04 | 17 | 61 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 5.60e-04 | 17 | 61 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 5.60e-04 | 17 | 61 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 5.60e-04 | 17 | 61 | 2 | C0751780 | |
| Disease | May-White Syndrome | 5.60e-04 | 17 | 61 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 5.60e-04 | 17 | 61 | 2 | C0751781 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 5.73e-04 | 78 | 61 | 3 | EFO_0022187 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 6.30e-04 | 18 | 61 | 2 | C0751779 | |
| Disease | Familial aplasia of the vermis | 7.80e-04 | 20 | 61 | 2 | cv:C0431399 | |
| Disease | Deep Vein Thrombosis | 8.61e-04 | 21 | 61 | 2 | C0149871 | |
| Disease | free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 8.61e-04 | 21 | 61 | 2 | EFO_0022277 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 8.61e-04 | 21 | 61 | 2 | EFO_0022246 | |
| Disease | docosahexaenoic acid to total fatty acids percentage | 8.61e-04 | 21 | 61 | 2 | EFO_0022262 | |
| Disease | Venous Thrombosis | 8.61e-04 | 21 | 61 | 2 | C0042487 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 1.02e-03 | 95 | 61 | 3 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.05e-03 | 96 | 61 | 3 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | executive function measurement | 1.08e-03 | 376 | 61 | 5 | EFO_0009332 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.39e-03 | 106 | 61 | 3 | EFO_0008317, EFO_0008596 | |
| Disease | corneal endothelial cell measurement | 1.47e-03 | 108 | 61 | 3 | EFO_0010079 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.51e-03 | 109 | 61 | 3 | EFO_0004639, EFO_0008317, EFO_0008596 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.55e-03 | 110 | 61 | 3 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.55e-03 | 110 | 61 | 3 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.55e-03 | 110 | 61 | 3 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | lipoprotein A measurement | 1.63e-03 | 112 | 61 | 3 | EFO_0006925 | |
| Disease | Familial aplasia of the vermis | 1.76e-03 | 30 | 61 | 2 | C0431399 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 1.88e-03 | 31 | 61 | 2 | C1335167 | |
| Disease | glycoprotein measurement | 1.94e-03 | 119 | 61 | 3 | EFO_0004555 | |
| Disease | Large cell carcinoma of lung | 2.00e-03 | 32 | 61 | 2 | C0345958 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MEHKEVVLLLLLFLK | 1 | Q02325 | |
| IKMKIALRVLHLEKR | 646 | A0FGR8 | |
| EKMALVKLAKLHEQL | 466 | Q9UJX2 | |
| ITLLEHLMKEFLDKK | 46 | O43683 | |
| KMLKKLRDEGHRVLI | 1031 | Q8TDI0 | |
| KIALREIRMLKQLKH | 46 | Q5MAI5 | |
| KEGLEKLHDMIIKRR | 176 | P40617 | |
| KIHLKRTKLDLLMNK | 366 | O60423 | |
| LELKLDKLVKLCIAM | 31 | Q15057 | |
| DILERAKKKMVLDHL | 921 | O14646 | |
| LLRHQKLKLDTQMKL | 1386 | Q96MT7 | |
| MKELLRLKHCKHLLT | 1 | Q8WY50 | |
| HQKKLMLAVRKLAEL | 591 | Q8WXD9 | |
| VIRKKLVHKTLDMIK | 116 | Q58FF3 | |
| KDIMVALRKLLAKLL | 286 | Q8NH19 | |
| LQIKLKIEDFILHKM | 371 | Q04759 | |
| KRKLKIMIHQVDELK | 516 | Q5T655 | |
| KKVMELLVHLNKRIK | 56 | Q5VYK3 | |
| HLLTIKETIRKMIKE | 131 | Q5T0W9 | |
| KLKTMKHLLLLLLCV | 11 | P02675 | |
| MSLKHLTKKLLNRDI | 301 | Q9H9L3 | |
| LHKREAILAKKEALM | 936 | Q2M1P5 | |
| ERLLKHKLKVQEEML | 561 | Q96PP9 | |
| RKMLSHKMKVLEELL | 546 | Q8N8V2 | |
| ERLKMLALLKRKDLA | 41 | Q8WXI9 | |
| MSAKVRLKKLEQLLL | 1 | Q9Y5S2 | |
| LLKKMLLIDADLRIT | 501 | Q9H422 | |
| MEHKEVVLLLLLFLK | 1 | Q15195 | |
| KDLLRKALILMNSKH | 536 | Q6ZMV5 | |
| KIAMREIKLLKQLRH | 46 | Q92772 | |
| TKTHKLEKLMIRLGL | 521 | Q9H461 | |
| LMELKILEALRKKDK | 146 | Q9NR20 | |
| RLRQKMKHEKDRLLL | 2941 | Q9H799 | |
| IERAKKKMVLDHLVI | 926 | O14647 | |
| KRQLLKMEHLLLKVL | 321 | P78396 | |
| QKDLLTHKILKLEMV | 881 | Q86WZ0 | |
| REHLEMLIDQLKIKL | 1351 | Q8IWJ2 | |
| MEHKEVVLLLLLFLK | 1 | P08519 | |
| SMEKKLLSRHLKQLL | 891 | Q6IQ26 | |
| LKVLLALKLHKMREE | 211 | P09913 | |
| KKRHAELKMDQALLL | 71 | Q68CP4 | |
| ELVELHLKLMRKIGK | 66 | Q96T23 | |
| LRLGVLKKKAMLHQE | 366 | P21817 | |
| KKKILLNIEHRIMLR | 2256 | P42345 | |
| ELEDIAKLKMILLRL | 311 | Q9NZ71 | |
| KATLKMLLDHLKLVA | 951 | Q5VT97 | |
| EKQRLHLKKFLLDRM | 36 | Q8TBZ9 | |
| RLKELLTMLQLKKDL | 491 | Q6ZMZ3 | |
| LVLHALEIKALRMKL | 126 | P0DP42 | |
| MEHKEVVLLLLLFLK | 1 | Q16609 | |
| KVRLHLAKDILMIQE | 26 | Q9NSN8 | |
| ILPRVVKMHLKFDLK | 241 | O60331 | |
| LHVKDLEFLLNKLMK | 181 | Q7Z4L9 | |
| LVVLKELKAIMKRDL | 866 | Q9UPS6 | |
| MEHKEVVLLLLLFLK | 1 | P00747 | |
| LVETQMKKLEIKLRH | 891 | Q8TAQ2 | |
| MLALVLHQKRKRLFL | 241 | Q9NWW5 | |
| RSLKLTAHKKILMEE | 311 | Q9UII5 | |
| RERLLLKFIKIMKHL | 906 | Q13905 | |
| MLKVLDHKDRVLKLL | 1016 | Q9H0E3 | |
| MRLKKAIHLKKLNFL | 301 | Q6ZSB9 | |
| MTLKKLNRLAHIRLK | 96 | Q13769 | |
| GMSLDIVLKKVKHRL | 111 | Q9NRD5 | |
| LKLIDVLKRQKMHIE | 356 | Q8N6V9 |